Clinical Trial Update: The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the combination of ATRA and Danazol as second-line treatment for adults with autoimmune thrombocytopenia (ITP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Thrombocytopenia

Drugs mentioned

• ATRA (all-trans retinoic acid)
• Danazol (danazol)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Autoimmune Thrombocytopenia | Phase 2 | Status: COMPLETED